Jump to main content
Jump to site search


Nebulizing novel multifunctional nanovesicles: the impact of macrophage-targeted-pH-sensitive archaeosomes on pulmonary surfactant

Abstract

In this work, a NE-U22 vibrating mesh Omron nebulizer was used to deliver Lissamine™ rhodamine B 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine triethylammonium salt (Rh-PE) and 8-Hydroxypyrene-1,3,6-trisulfonic acid trisodium salt (HPTS)/ p-xylene-bis-pyridinium bromide (DPX) double labelled macrophage-targeted pH-sensitive archaeosomes (ApH, 174  48 nm, - 30  13 mV unilamellar nanovesicles made of dioleoyl-sn-glycero-3-phosphoethanolamine: [total polar archaeolipids from the hyperhalophile archaebacteria Halorubrum tebenquichense]: cholesterylhemisuccinate 4.2:2.8:3 w:w:w) - on J774A.1 cells covered by Prosurf pulmonary surfactant (PS) monolayer at or below the equilibrium surface pressure . The uptake and cytoplasmic drug release from ApH were assessed by flow cytometry of Rh-PE and HPTS fluorescence respectively. Despite of being soft matter submitted to dismantling interactions of shear stress of nebulization and contact with surfactant barrier, at least a fraction of nebulized ApH was found to be stable enough to execute higher cytoplasmic delivery than archaeolipids lacking vesicles. Nebulized ApH increased the PS tensioactivity below e only, out of the physiological range. This would mean that in vivo, changes in lung surfactant function induced by nebulized nanovesicles, is poorly likely to occur. The cytoplasmic delivery from ApH slightly decreased across monolayers at , suggesting that nanovesicles crossed the PS in a fashion inversely related to monolayer compression. Laurdan Generalized Polarization and Fluorescence Anisotropy were used to reveal that nanovesicles neither depleted B and C proteins of the PS, not increased its fluidity. Together with the feasibility of cytoplasmic drug delivery upon nebulization, our results suggest that ApH are structurally unique nanovesicles that would not induce biophysical changes leading to PS inactivation, and open the door to future deeper translational studies.

Back to tab navigation

Publication details

The article was received on 20 Jun 2017, accepted on 06 Sep 2017 and first published on 07 Sep 2017


Article type: Paper
DOI: 10.1039/C7TB01694H
Citation: J. Mater. Chem. B, 2017, Accepted Manuscript
  •   Request permissions

    Nebulizing novel multifunctional nanovesicles: the impact of macrophage-targeted-pH-sensitive archaeosomes on pulmonary surfactant

    M. J. Altube, A. Cutro, L. Bakas, M. J. Morilla, E.A. Disalvo and E. L. L. romero, J. Mater. Chem. B, 2017, Accepted Manuscript , DOI: 10.1039/C7TB01694H

Search articles by author

Spotlight

Advertisements